Clinical Laserthermia Systems AB (publ) - Asset Resilience Ratio
Clinical Laserthermia Systems AB (publ) (CLS-B) has an Asset Resilience Ratio of 0.31% as of June 2023. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2017–2022)
This chart shows how Clinical Laserthermia Systems AB (publ)'s Asset Resilience Ratio has changed over time. Check Clinical Laserthermia Systems AB (publ) PP&E and investment ratio to assess the company's strategic physical and investment asset allocation.
Liquid Assets Composition Over Time
This chart breaks down Clinical Laserthermia Systems AB (publ)'s liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Clinical Laserthermia Systems AB (publ) market cap and net worth.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | Skr0.00 | 0% |
| Short-term Investments | Skr139.00K | 0.31% |
| Total Liquid Assets | Skr139.00K | 0.31% |
Asset Resilience Insights
- Limited Liquidity: Clinical Laserthermia Systems AB (publ) maintains only 0.31% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Clinical Laserthermia Systems AB (publ) Industry Peers by Asset Resilience Ratio
Compare Clinical Laserthermia Systems AB (publ)'s asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
APT Medical Inc
SHG:688617 |
Medical Devices | 8.63% |
|
Medacta Group SA
SW:MOVE |
Medical Devices | 0.86% |
|
Jafron Biomedical Co Ltd
SHE:300529 |
Medical Devices | 39.15% |
|
Shanghai MicroPort EV MedTech Co. Ltd. A
SHG:688351 |
Medical Devices | 49.23% |
|
HOB Biotech Group Corp Ltd
SHG:688656 |
Medical Devices | 2.62% |
|
Shanghai General Healthy Information and Technology Co. Ltd.
SHG:605186 |
Medical Devices | 0.84% |
|
CareRay Digital Medical Technology Co Ltd
SHG:688607 |
Medical Devices | 16.21% |
|
Wuhan Easy Diagnosis Biomedicine Co Ltd Class A
SHE:002932 |
Medical Devices | 34.47% |
Annual Asset Resilience Ratio for Clinical Laserthermia Systems AB (publ) (2017–2022)
The table below shows the annual Asset Resilience Ratio data for Clinical Laserthermia Systems AB (publ).
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2022-12-31 | 0.28% | Skr139.49K ≈ $15.01K |
Skr49.51 Million ≈ $5.33 Million |
-43.86pp |
| 2021-12-31 | 44.14% | Skr29.46 Million ≈ $3.17 Million |
Skr66.74 Million ≈ $7.18 Million |
+18.74pp |
| 2020-12-31 | 25.40% | Skr11.28 Million ≈ $1.21 Million |
Skr44.40 Million ≈ $4.78 Million |
+16.07pp |
| 2019-12-31 | 9.32% | Skr3.60 Million ≈ $387.93K |
Skr38.67 Million ≈ $4.16 Million |
-31.96pp |
| 2018-12-31 | 41.28% | Skr23.95 Million ≈ $2.58 Million |
Skr58.02 Million ≈ $6.24 Million |
+10.97pp |
| 2017-12-31 | 30.31% | Skr13.62 Million ≈ $1.47 Million |
Skr44.94 Million ≈ $4.84 Million |
-- |
About Clinical Laserthermia Systems AB (publ)
Clinical Laserthermia Systems AB (publ) engages in the development of treatment tools for diseased tissue under the TRANBERG brand in Sweden. It offers TRANBERG, a thermal therapy system designed to deliver laser energy to heat the target tissue. The company also provides mobile laser unit, a controlling component with a wavelength of 1064 nanometers that provides multiple options to control trea… Read more